Biotech investors are far more selective than they were during the pandemic-era boom, JPMorgan's top EMEA healthcare investment bankers told CNBC. Many biotech companies are now pursuing a dual-track ...

The Supreme Court on Monday directed the Central Board of Secondary Education (CBSE) to take all necessary steps to declare the Class 12 Improvement Examination results as soon as possible. The court ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Timothy Coughlin to its Board of Directors and as Chair of the Audit Committee, effective June ...

The CBSE Class 12 Biotechnology syllabus for the 2026-27 academic year remains same as the previous year. It outlines the required chapters and subjects, assessment criteria, project work guidelines, ...

CBSE Class 10 Second Board Result 2026 LIVE: The Class 10 board exam results will be announced and available on cbse.gov.in. Follow the blog for latest updates on results, direct link and more. CBSE ...

The 2026 academic session marked the introduction of CBSE's new two-exam format for Class 10 students.Under this system, the first board examination held in February is compulsory for all students.

The wide-ranging geopolitical rivalry between Beijing and Washington could soon expand into biotechnology, raising the prospect of fresh tensions even as American pharmaceutical firms have turned to ...

Kosloff is a co-chair of a working group with the China Strategy Initiative at the Council on Foreign Relations and a senior fellow at American Economic Liberties Project. China’s rise is happening ...

Vir Biotechnology develops monoclonal antibodies and RNA-based therapeutics targeting infectious diseases such as COVID-19, hepatitis B, influenza A, and HIV. It generates revenue primarily through ...

Biopharma companies appear to be more willing to go public after a long drought. Just this week, GLP-1 developer Kailera Therapeutics and proteomics company Alamar Biosciences launched IPO roadshows ...